Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Long-term Investments
Investments the company intends to hold for more than a year.
Beta Bionics, Inc.NASDAQ: BBNX
Long-term Investments · Q1 FY2026 · quarter ended Mar 2026
Long-term investments falls 37.7% from a year ago
Long-term investments stood at $39.87M at the end of Q1 FY2026, down 37.7% from a year earlier and down 12.3% from the prior quarter.
Context
- Long-term investments amounted to 13.1% of total assets at the end of Q1 FY2026, down 5.8 pp from a year earlier.
- Long-term investments increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether long-term investments keeps falling in the next quarterly balance sheet after a -37.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 45.43M USD
- Year-over-year change
- —
| Period | Period end | Long-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 45.43M | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Long-term Investments vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so long-term investments is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -37.7% is the 6th highest of 7, against a peer median of -5.8%.
- Long-term investments amounts to 13.1% of total assets for BBNX, versus a peer median of 1.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | DKK 2.33B DKK | -11.7% | +23.1% | 0.4% | |
| Jun 2026 | $209.5M USD | +80.9% | +125.5% | 3.2% | |
| Mar 2026 | $199.4M USD | +1992.4% | +226.2% | 74.2% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $75M USD | — | — | 1.6% |
| Mar 2026 | $56.49M USD | -20.4% | — | 4.9% | |
| Mar 2026 | $39.87M USD | -37.7% | — | 13.1% | |
| Jun 2026 | $19.1M USD | +0.0% | +10.2% | 0.6% | |
| Mar 2026 | $747K USD | -95.5% | +36.7% | 0.1% | |
| Peer median (excluding BBNX) | — | -5.8% | +36.7% | 1.6% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.